
|Articles|October 19, 2009
Emerging Pharma Leadership Awards - Elizabeth Mutisya
Advertisement
Elizabeth Mutisya,
VP, US Medical Affairs, CMO,
Solvay Pharmaceuticals
Download Adobe Flash Player
“We need to do a better job of delineating the value our industry provides in addressing medical problems. Health economics allows us to better quantify the benefits of our solutions to patient outcomes, health-related quality of life, and individuals involved in patient care.” Listen to the Podcast for more coverage.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
3
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5




